CCA
IMUX icon

Catalyst Capital Advisors’s Immunic IMUX Stock Holding History

Catalyst Capital Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14
Closed -$138K – 508
2015
Q1 		$138K Hold
14
– – 0.02% 292
2014
Q4 		$137K Buy
+14
New +$108K 0.02% 309

Other funds holding IMUX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Catalyst Capital Advisors's IMUX Position: Q2 2015 in Review

Catalyst Capital Advisors sold out of Immunic (IMUX) in Q2 2015, closing a stake of 14 shares — an estimated $138K sold.

Catalyst Capital Advisors first reported a position in IMUX in Q4 2014 and held it in 2 quarters. The position peaked at $138K in Q1 2015. 52 funds tracked by Wall St. Rank hold IMUX as of Q2 2015.

  • Catalyst Capital Advisors reported no remaining Immunic position as of Q2 2015 after selling out during the quarter.
  • Catalyst Capital Advisors sold 14 Immunic shares in Q2 2015, an estimated $138K.
  • Catalyst Capital Advisors first reported a position in Immunic in Q4 2014 and held it in 2 quarters.
  • Catalyst Capital Advisors's Immunic position peaked at $138K in Q1 2015.
  • 52 funds tracked by Wall St. Rank held Immunic as of Q2 2015.

Based on Catalyst Capital Advisors's 13F filing for Q2 2015, filed 12 Aug 2015.